Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Recall: Manufacturing issues believed behind CEO departure
Fierce Pharma Manufacturing
Thursday, February 23, 2012 - 12:04pm
tags:
recalls, JNJ, William Weldon, Pharma CEOs
MannKind Narrows Loss
Yahoo/Zacks
Thursday, February 23, 2012 - 11:59am
tags:
earnings, MannKind
The Battle For The Anti-Coagulation Market
Seeking Alpha
Thursday, February 23, 2012 - 11:58am
tags:
anticoagulants, Pfizer, Sanofi, Bristol-Myers Squibb
Chelsea Therapeutics: FDA Panel Live Blog
TheStreet.com
Thursday, February 23, 2012 - 10:43am
tags:
FDA, advisory panels, Chelsea Therapeutics, Northera
4 Compelling Alternatives To Vertex Pharma
Seeking Alpha
Thursday, February 23, 2012 - 10:42am
tags:
Vertex Pharmaceuticals, Acorda, Aveo Pharmaceutical, Jazz Pharmaceuticals, Momenta
Vivus rockets 99% on FDA nod
Marketwatch
Thursday, February 23, 2012 - 10:41am
tags:
FDA, Vivus, obesity, Qnexa
Satori snags $15M to fuel a trial on Alzheimer's drug
Fierce Biotech
Thursday, February 23, 2012 - 10:40am
tags:
Satori, Alzheimer's disease, amyloid beta
Novartis Urged To Drop Gleevec Patent Case
Pharmalot
Thursday, February 23, 2012 - 10:38am
tags:
Gleevac, Novartis, patents
Par Pharma Absorbs Edict Pharma
Yahoo/Zacks
Thursday, February 23, 2012 - 10:37am
tags:
Edict Pharmaceuticals, Par Pharmaceutical
Medicines Co 4Q profit slides, trumps expectations
Yahoo/AP
Thursday, February 23, 2012 - 10:36am
tags:
earnings, Medicines Company
Paladin and Somaxon Announce Filing of New Drug Submission for Silenor
Yahoo
Thursday, February 23, 2012 - 10:36am
tags:
Paladin, Somaxon, Silenor, Canada, insomnia
MAP Pharmaceuticals Issued Additional U.S. Patent for Methods of Achieving Rapid Treatment of Migraine Based Upon Pharmacokinetic Profile
Yahoo
Thursday, February 23, 2012 - 10:35am
tags:
migraines, MAP Pharmaceuticals, patents
Johnson & Johnson CEO is Out, but not Gone
TheStreet.com
Thursday, February 23, 2012 - 10:34am
tags:
William Weldon, Pharma CEOs, JNJ
Ranbaxy Reports $606 Million Loss After U.S. Settlement
Bloomberg
Thursday, February 23, 2012 - 10:33am
tags:
Ranbaxy, earnings
FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
Washington Post, DC
Wednesday, February 22, 2012 - 10:12pm
tags:
FDA, Vivus, obesity, Qnexa, advisory panel
Santarus, Depomed settle dispute with Lupin
Reuters
Wednesday, February 22, 2012 - 10:09pm
tags:
Depomed, Lupin, Santarus, Glumetza, diabetes, generics
Theravance: A $1.5 Billion Company With An $8 Billion Product
Seeking Alpha
Wednesday, February 22, 2012 - 5:47pm
tags:
Theravance, GSK, Pfizer, Relovair, Advair, AstraZeneca, asthma, COPD
Prevnar trial results needed for CDC recommendation
Reuters
Wednesday, February 22, 2012 - 5:42pm
tags:
Prevnar 13, vaccines, CDC, pneumonia
Novartis' Rasilez to Carry Warning Novartis' Rasilez to Carry Warning
Yahoo/AP
Wednesday, February 22, 2012 - 5:36pm
tags:
Mylan, guidance
Teva Pays $250M To Settle Propofol Lawsuits
Pharmalot
Wednesday, February 22, 2012 - 11:47am
tags:
Teva Pharmaceuticals, settlements, propofol, anesthesia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.